ISSN: 2278-0238

Internationale Zeitschrift für Forschung und Entwicklung in Pharmazie und Biowissenschaften

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

INTEGRATION OF PROJECT-PRODUCT LIFECYCLE IN PHARMACEUTICAL INDUSTRY

Divya Chauhan, Nusrat Khan

One meaningful and holistic approach to today’s current challenges within the pharmaceutical industry is to focus on Product Lifecycle Management (PLM). PLM has provided many pharmaceutical organizations with the ability to get products to market quicker, ensure greater regulatory compliance and efficiencies while reducing development costs. A product life cycle is a conceptual map of - where a product's sales are and where they may be headed. However, it has no comment on what to do with the product. If a company believes its product is entering the decline phase, it will probably create a plan to either rejuvenate the product or cease production, but that is not inherent in the product life cycle. Thus, comes the concept of project life cycle (PLC), which is all about action. A project life cycle maps out the steps needed to complete a project with specific targeted results. Although these two lifecycles are talked about separately but if integrated can be of greater use to an organization